A robust QMS ensures regulatory submission success and ongoing compliance by aligning with GMP, ISO 13485, risk management, data integrity, and supplier controls. Expert consultations aid readiness.
Align labeling, claims, and evidence per FDA and Health Canada rules to avoid delays and enforcement. Use substantiation matrices, clinical evidence, and strategic regulatory planning for US and Canada compliance.
Conduct a thorough regulatory gap analysis addressing US FDA and Health Canada requirements, labeling, claims substantiation, risk management (ISO 14971), and post-market surveillance to ensure smooth, compliant market entry.
This guide details preparing regulatory files for medical devices, cosmetics, and pharmaceuticals, emphasizing compliance with FDA and Health Canada standards, proper formatting, and benefits of expert consultancy.
This guide outlines how to avoid US FDA and Health Canada approval delays by thorough submission planning, quality readiness, agency engagement, and partnering with Arora 297 Consultancy for expert regulatory…
This playbook guides creating compliant FDA and Health Canada regulatory files by detailing dossier components, addressing deficiencies, strategic planning, labeling compliance, GMP/ISO standards, and eCTD submission for faster approvals.
Regulatory intelligence enables proactive, risk-based compliance by monitoring FDA and Health Canada updates, integrating with quality systems, and supporting strategic submissions. Arora 297 offers tailored consulting and free assessments in…
Regulated product launch delays often stem from regulatory oversights, submission challenges, and quality issues. Structured project management, robust QMS, proactive communication, and expert consultancy like Arora 297 mitigate risks and…
This playbook guides decision-makers on entering regulated markets, covering product classification, regulatory pathways, timelines, GMP compliance, ISO 13485 QMS, and post-market vigilance to ensure smooth, compliant market entry.
This guide outlines a step-by-step approach to navigate US FDA and Health Canada regulatory approvals, emphasizing phased planning, compliance strategies, risk management, dossier preparation, and post-market surveillance for successful market…
Call Now Button